Arca
Skip to content

Pouchitis

Drug research and approvals for pouchitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 6 studies of pouchitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and FDA has 0 approved and 11 open orphan designations naming it.

  • Recruiting worldwide: 6
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 6 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

3 in phase 3, 4 in phase 2, 3 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Ustekinumab
Phase 3 Interleukin-12 inhibitor
Vedolizumab
Phase 3 Integrin alpha-4/beta-7 inhibitor
Alicaforsen
Phase 3 Intercellular adhesion molecule-1 mRNA 3'UTR antisense inhibitor
Liraglutide
Phase 2 Glucagon-like peptide 1 receptor agonist
Tofacitinib
Phase 2 Janus Kinase (JAK) inhibitor
Vimekofusp
Phase 2
Metronidazole
Phase 1 DNA inhibitor
Fosfomycin
Phase 1 UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor

How Its Trials Ended

41 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 12 whose ending is known, 17% met their primary endpoint, 8% missed it and 75% stopped early.

  • Completed, result not reported1332%
  • Ongoing922%
  • Status unknown717%
  • Stopped: other or unclear512%
  • Met its primary endpoint25%
  • Stopped: enrollment or feasibility25%
  • Missed its primary endpoint12%
  • Stopped: lack of efficacy12%
  • Stopped: funding12%

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 19, 2020A combined phase 2/3 12-week, randomized, double-blind, placebo-controlled study investigating the efficacy of amt-101 in subjects with chronic…AMT-101Applied Molecular Transport Inc.Ongoing
Jan 18, 2019Randomized trial of fecal microbiota transplantation versus placebo for the induction of remission in patients with active pouchitisFecal microbiota for transplantation (fmt), human biotherapy (hbt)Mcmaster UniversityPending
May 5, 2016A randomized, double-blind, placebo-controlled phase 4 study to evaluate the efficacy and safety of entyvio (vedolizumab iv) in the treatment of chronic…EntyvioTakeda Pharmaceuticals USAClosed

FDA Orphan Designations

Approved first, then open designations, newest first
Apr 29, 2024(-)-Epigallocatechin 3-gallateTreatment of pouchitisPharmassetX LLCDesignated
Nov 8, 2022Recombinant human interleukin-10 fusion proteinTreatment of pouchitisApplied Molecular Transport, Inc.Designated
Oct 18, 2022RifamycinTreatment of PouchitisCosmo Technologies, Ltd.Designated
Mar 15, 2021VedolizumabTreatment of PouchitisTakeda Development Center Americas, Inc.Designated
Nov 2, 2020EXE-346, a Live Biotherapeutic Product (LBP), contains…Treatment of pouchitisExeGi Pharma, LLC.Designated
Apr 26, 2011MetronidazoleTreatment of pouchitisS.L.A. Pharma Limited (UK)Designated
Sep 17, 2008MetronidazoleTreatment of pouchitisAvivia Project BVDesignated
Dec 19, 2007Spherical carbon adsorbentTreatment of chronic pouchitisOcera Therapeutics, Inc.Designated
Jun 14, 2005ClotrimazoleTopical treatment of children and adults with pouchitisAesRx, LLCDesignated
Jan 15, 2002Lactic acid bacteria (Lactobacilli, Bifidobacteria, and…Treatment of active chronic pouchitisVSL Pharmaceuticals, Inc.Designated
Jan 15, 2002Lactic acid bacteria (Lactobacilli, Bifidobacteria, and…Prevention of disease relapse in patients with chronic pouchitisVSL Pharmaceuticals, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.